D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
SM Energy
SM
$3.14B
| $19.5M | 0.03% |
1,115,736
-179,125
| -14% | -$3.13M |
|
552
Travere Therapeutics
TVTX
$2.43B
| $19.4M | 0.03% |
858,589
+81,069
| +10% | +$1.83M |
|
553
Premier
PINC
$2.21B
| $19.4M | 0.03% |
561,535
+300,748
| +115% | +$10.4M |
|
554
Perrigo
PRGO
$3.04B
| $19.3M | 0.02% |
400,788
-17,128
| -4% | -$825K |
|
555
Louisiana-Pacific
LPX
$6.64B
| $19.3M | 0.02% |
791,673
+190,690
| +32% | +$4.65M |
|
556
Puma Biotechnology
PBYI
$229M
| $19.2M | 0.02% |
495,226
+425,991
| +615% | +$16.5M |
|
557
Smith & Wesson
SWBI
$416M
| $19.2M | 0.02% |
2,670,116
-269,361
| -9% | -$1.93M |
|
|
UMPQ
558
DELISTED
Umpqua Holdings Corp
UMPQ
| $19.2M | 0.02% |
1,161,608
+267,360
| +30% | +$4.41M |
|
559
iShares Core MSCI Emerging Markets ETF
IEMG
$105B
| $19M | 0.02% |
367,588
-64,575
| -15% | -$3.34M |
|
560
Upbound Group
UPBD
$1.47B
| $18.9M | 0.02% |
907,219
+30,477
| +3% | +$636K |
|
561
Ambev
ABEV
$35.2B
| $18.9M | 0.02% |
4,396,534
+2,915,529
| +197% | +$12.5M |
|
562
Macy's
M
$4.56B
| $18.8M | 0.02% |
784,363
+735,445
| +1,503% | +$17.7M |
|
563
Burlington
BURL
$17.6B
| $18.8M | 0.02% |
120,121
-321,230
| -73% | -$50.3M |
|
564
Graphic Packaging
GPK
$6.14B
| $18.8M | 0.02% |
1,488,344
+1,224,884
| +465% | +$15.5M |
|
|
RDUS
565
DELISTED
Radius Health, Inc.
RDUS
| $18.8M | 0.02% |
941,650
+286,310
| +44% | +$5.71M |
|
566
Pultegroup
PHM
$26.7B
| $18.7M | 0.02% |
670,549
-16,067
| -2% | -$449K |
|
567
NETSCOUT
NTCT
$1.8B
| $18.6M | 0.02% |
663,188
+39,168
| +6% | +$1.1M |
|
|
TIF
568
DELISTED
Tiffany & Co.
TIF
| $18.6M | 0.02% |
176,293
-173,006
| -50% | -$18.3M |
|
|
BNFT
569
DELISTED
Benefitfocus, Inc.
BNFT
| $18.6M | 0.02% |
374,991
+109,553
| +41% | +$5.43M |
|
570
Expeditors International
EXPD
$16.5B
| $18.5M | 0.02% |
244,142
+82,494
| +51% | +$6.26M |
|
571
MKS Inc. Common Stock
MKSI
$7.43B
| $18.5M | 0.02% |
198,957
-273,777
| -58% | -$25.5M |
|
572
Copel
ELP
$6.84B
| $18.3M | 0.02% |
4,926,100
+368,210
| +8% | +$1.37M |
|
573
Oshkosh
OSK
$8.75B
| $18.2M | 0.02% |
242,516
-12,484
| -5% | -$938K |
|
574
Darden Restaurants
DRI
$24.7B
| $18.2M | 0.02% |
149,596
-243,504
| -62% | -$29.6M |
|
575
Newmont
NEM
$86.2B
| $18.1M | 0.02% |
505,335
+284,157
| +128% | +$10.2M |
|